VEGF-A Predicts the Development of Moderate or Severe Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients

被引：0
|
作者：
Daly, K. [1 ,2 ,3 ]
Stack, M. [1 ,2 ,3 ]
Eisenga, M. [1 ,2 ,3 ]
Keane, J. [1 ,2 ,3 ]
Zurakowski, D. [1 ]
Blume, E. [1 ,2 ,3 ]
Briscoe, D. [1 ,2 ,3 ]
机构：
[1] Boston Childrens Hosp, Transplant Res Program, Boston, MA USA
[2] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[3] Boston Childrens Hosp, Dept Med, Boston, MA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
2097
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [1] VEGF-A Predicts the Development of Moderate or Severe Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Daly, K.
    Stack, M.
    Eisenga, M.
    Keane, J.
    Zurakowski, D.
    Blume, E.
    Briscoe, D.
    [J]. TRANSPLANTATION, 2014, 98 : 4 - 5
  • [2] Cardiac allograft vasculopathy in pediatric heart transplant recipients
    Hathout, E
    Beeson, WL
    Kuhn, M
    Johnston, J
    Fitts, J
    Razzouk, A
    Bailey, L
    Chinnock, RE
    [J]. TRANSPLANT INTERNATIONAL, 2006, 19 (03) : 184 - 189
  • [3] Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients
    Daly, Kevin P.
    Stack, Maria
    Eisenga, Michele F.
    Keane, John F.
    Zurakowski, David
    Blume, Elizabeth D.
    Briscoe, David M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : 434 - 442
  • [4] Aspirin Use and the Development of Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients
    D'Addese, L.
    Cantor, R.
    Koehl, D.
    Reardon, L.
    Ameduri, R.
    Bock, M.
    Morrison, A.
    White, S.
    Wisotzkey, B.
    Kirklin, J. K.
    Godown, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S119 - S119
  • [5] Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
    Kobayashi, Daisuke
    Du, Wei
    L'Ecuyer, Thomas J.
    [J]. PEDIATRIC TRANSPLANTATION, 2013, 17 (05) : 436 - 440
  • [6] VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients
    Daly, Kevin P.
    Seifert, Michael E.
    Chandraker, Anil
    Zurakowski, David
    Nohria, Anju
    Givertz, Michael M.
    Karumanchi, S. Ananth
    Briscoe, David M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (01): : 120 - 128
  • [7] Pediatric Heart Transplant Recipients and Cardiac Allograft Vasculopathy The Importance of Hemodynamics
    Eisen, Howard J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (05) : 558 - 560
  • [8] Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis
    D'Addese, Laura
    Cantor, Ryan S.
    Koehl, Devin
    Reardon, Leigh
    Ameduri, Rebecca
    Bock, Matthew
    Morrison, Adam
    White, Shelby
    Wisotzkey, Bethany
    Kirklin, James K.
    Godown, Justin
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (01): : 115 - 123
  • [9] ASSESSMENT OF CARDIAC ALLOGRAFT VASCULOPATHY IN JAPANESE PEDIATRIC HEART TRANSPLANT RECIPIENTS.
    Kogaki, Shigetoyo
    Fukushima, Norihide
    Takahashi, Kunihiko
    Uchikawa, Toshiki
    Ishii, Ryo
    Higeno, Ryouta
    Ichimori, Hiroaki
    Okada, Yoko
    Ishida, Hidekazu
    Sawa, Yoshiki
    Ozono, Keiichi
    [J]. PEDIATRIC TRANSPLANTATION, 2013, 17 (03) : 317 - 317
  • [10] Percutaneous coronary interventions for cardiac allograft vasculopathy in pediatric heart transplant recipients
    Meena, N. K.
    Sachdeva, R.
    Frazier, E. A.
    Sachdeva, R.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 372 - 372
12345